J&J seeks US clearance for COVID-19 vaccine booster doses
@WSJ4 years ago
A panel of U.S. government vaccine advisers expressed general support for giving Covid-19 boosters to the immunocompromised, though it said it would wait for regulatory clearance before making a formal recommendation on.wsj.com
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
@axios.com4 years ago
AstraZeneca CEO: "We need to do an additional study" on COVID vaccine
@WSJ3 years ago
Regulatory clearance of the Pfizer-BioNTech Covid-19 vaccine for young children may not come until November, according to a person familiar with the matter on.wsj.com
Pfizer and BioNTech began the formal process of seeking FDA clearance for a Covid-19 booster shot, submitting data showing a third vaccine dose generated higher levels of neutralizing antibodies against the original virus and its Beta and Delta variants on.wsj.com
@truthout.org4 years ago
Trump Blocks FDA on Stricter COVID-19 Vaccine Standards
